WO1999062573A1 - Ultraviolet transmitter for haemodialysis - Google Patents
Ultraviolet transmitter for haemodialysis Download PDFInfo
- Publication number
- WO1999062573A1 WO1999062573A1 PCT/EP1999/003446 EP9903446W WO9962573A1 WO 1999062573 A1 WO1999062573 A1 WO 1999062573A1 EP 9903446 W EP9903446 W EP 9903446W WO 9962573 A1 WO9962573 A1 WO 9962573A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dialysate
- burner
- dialysis
- free
- housing
- Prior art date
Links
- 238000001631 haemodialysis Methods 0.000 title claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 5
- 239000012466 permeate Substances 0.000 claims abstract description 5
- 239000002351 wastewater Substances 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims abstract 2
- 230000000322 hemodialysis Effects 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 2
- 239000002158 endotoxin Substances 0.000 abstract description 11
- 239000002510 pyrogen Substances 0.000 abstract description 5
- 230000005855 radiation Effects 0.000 abstract description 2
- 230000003204 osmotic effect Effects 0.000 abstract 1
- 238000000502 dialysis Methods 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 239000012528 membrane Substances 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 4
- 150000002926 oxygen Chemical class 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000001223 reverse osmosis Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- -1 oxygen radicals Chemical class 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000036448 vitalisation Effects 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/168—Sterilisation or cleaning before or after use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1674—Apparatus for preparing dialysates using UV radiation sources for sterilising the dialysate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/168—Sterilisation or cleaning before or after use
- A61M1/1682—Sterilisation or cleaning before or after use both machine and membrane module, i.e. also the module blood side
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
- A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet
Definitions
- the invention relates to a UV lamp for treating liquids which are connected with the hemodialysis treatment of patients, comprising a housing in which the UV burner is arranged.
- liquids can be sterilized or disinfected by means of UV light irradiation.
- a dialysis machine is known (DE 196 40 840 AI), in which the disinfectant used for disinfection is sterilized with the aid of UV radiation.
- UV burners are also used to irradiate the osmosis water treated by reverse osmosis before the dialysate is processed.
- An additional UV burner can also be used in such a system to irradiate the dialysate (DD 284 603 B5).
- pathogens for example, can be “killed”, that they can nevertheless get into the patient's bloodstream and can carry out a wide variety of reactions there.
- pathogens for example, can be “killed”, that they can nevertheless get into the patient's bloodstream and can carry out a wide variety of reactions there.
- These can be allergic reactions, for example fever reactions could be attributed to the fact that such pathogens do not lead to an outbreak, for example, but can trigger reactions in the body that are very unpleasant for the treated patient.
- the dialysate should not contain any impurities, an "ultra-pure" dialysate is expected.
- Renal insufficiency patients are detoxified three times a week with the help of an artificial kidney. This detoxification is reduced to the principle that patient blood is passed in countercurrent to a suitable water circuit within an extracorporeal blood circuit. Water and blood are separated from each other by a semipermeable membrane, the dialysis membrane. The transfer of the urinary substances from the patient's blood to the dialysate (“wash water”) takes place by diffusion, osmosis and ultrafiltration.
- the possibility of treating liquid flows within a hemodialysis system is to be created within one housing with the aid of one radiator or more.
- the UV lamp according to the invention can be a mobile device, with a plurality of liquid lines with inlet and outlet being present, so that those liquid flows can be treated that occur anywhere in a hemodialysis system. Treatment is then to be understood as an action which not only kills germs, bacteria and pathogens but also changes them so that no more reactions occur in the body of the patient being treated. This is accomplished according to the invention by assigning the corresponding liquid lines to the vicinity of the burner, so that, for example, bacteria are not only killed in the conventional sense, but can also be broken down into particles which are no longer perceived as foreign bodies in the blood of the patient being treated , so that the typical body defense reactions do not occur. It is particularly important in connection with the online hemodialysis method that the bypass dialysate can be passed through one of the liquid lines.
- dialysate used can also be brought into the form of clean waste water. It no longer needs to be collected and disposed of separately, but can be discharged via the usual sewage system.
- the present invention has the effect that the well-being of the patient is significantly improved.
- disinfection processes with disinfectants could be dispensed with, so that no rinsing and disinfection phases are required. Even residues of the disinfectant can no longer arise.
- Tap water is demineralized using reverse osmosis. The permeate is formed.
- the demineralized water is fed to the dialysis machine via a hose.
- the dialysis machine mixes from the permeate and the dialysis concentrate a physical solution, which is compared to the uremic-laden blood Concentration gradient to the substances to be eliminated.
- the dialysate thus generated is heated to 37 ° C and degassed.
- the dialysate is now conducted past the dialysis membrane outside the dialysis machine in the extracorporeal circuit. On the other side of the dialysis membrane, the blood to be cleaned is passed in countercurrent.
- Germs are entered via couplings and also via the permeate. The germs find a good multiplication environment in the dialysate. Because the route of the dialysate in the dialyser is very complex, the mass of germs is deposited in the device and forms the so-called biofilm.
- the endotoxins represent the problem for the patient. Because of their small size, they are able to pass through the dialysis membrane and thus get into the patient's blood, which could suffer an endotoxin shock. 5. The oxygen transport capacity of the erythrocytes suffers from the influence of dialysis.
- the leukocytes recognize a foreign body in the dialysis membrane. They lie on the inside of the dialysis membrane.
- the leukocytes lose their function of capturing endotoxins.
- the present invention achieves:
- the UV rays generate oxygen radicals, saturated oxygen and ozone in the dialysate. 0 and 0 3 have a short half-life. It is expected that the O radicals and ozone will come together after a short flow to form saturated oxygen. This means that the dialysate is enriched with saturated oxygen and thus leads the dialysate enriched with free, saturated oxygen to the dialysis membrane. About the Dialysis membrane reaches part of the oxygen in the blood and thus compensates for the oxygen deficiency in the blood that occurs during dialysis, which leads to vitalization of the patient during and after dialysis. This means that the body's own barriers (the leukocytes) are activated to bind endocotoxins. The risk of excessive oxygenation of the blood cannot be overlooked. In this respect, due to the design, care must be taken that the UV burner is not placed too close to the dialysis membrane.
- Photochemistry actually degrades pollutants in water treatment and does not simply shift them to another matrix like conventional physical techniques such as activated carbon absorbers or filtration.
- a bypass is removed from the dialysis circuit after the UV burner and this already sterilized dialysate passes through a separate UV burner cell again.
- the dialysate treated in this way can then be administered to the patient as a substituate. It can then be safely assumed that absolute freedom from sterility, pyrogen and endotoxins has been produced.
- the substituate bypass can be additionally secured with a pyrogen and endotoxin filter.
- Fig. 1 of the drawing shows a schematic cross-sectional view through the housing of a device according to the invention.
- Fig. 2 shows schematically the liquid circuits during dialysis in a device according to the invention.
- an essentially cylindrical housing is designated, which is equipped with two UV burners 20 and 21. Air inlet and outlet openings are provided at the top and bottom. 30 designates a reflective coating of the inner housing in relation to the burner element 20.
- the housing 10 can be arranged separately from the dialysis device, but could also be integrated into this as well.
- liquid lines 11, 12 and 13 which stand for the individual liquid flows in a hemodialysis system. These can be straight runs 12 and 13. It can also be a serpentine arrangement, as is shown schematically in the circuit 11.
- the liquid flowing through the circuit 11 is treated very intensively by the burner 21 arranged on the inside, but is also acted upon from the outside by the burner 20, so that the desired effect is achieved, namely that the emerging liquid is free of foreign particles that are in the human body could trigger any reaction.
- the raw or osmosis water 30 reaches the first UV burner for the osmosis water via a reverse osmosis, this is designated in the figure with 1 HE.
- the osmosis water therefore enters the dialysis machine and thus reaches the actual dialysate circuit 31.
- the dialysate circuit contains the second and third burner (2nd unit and 3rd unit) as well as the dialyzer D.
- the blood circuit has been designated 33 and closes over the patient and the dialyzer.
- the fourth burner (4th U) is located in the substituate circuit 32.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99955226A EP1001819A1 (en) | 1998-06-04 | 1999-05-20 | Ultraviolet transmitter for haemodialysis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE29809867U DE29809867U1 (en) | 1998-06-04 | 1998-06-04 | UV lamp for hemodialysis |
DE29809867.9 | 1998-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999062573A1 true WO1999062573A1 (en) | 1999-12-09 |
Family
ID=8057990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/003446 WO1999062573A1 (en) | 1998-06-04 | 1999-05-20 | Ultraviolet transmitter for haemodialysis |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1001819A1 (en) |
DE (1) | DE29809867U1 (en) |
WO (1) | WO1999062573A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003035145A1 (en) * | 2001-10-18 | 2003-05-01 | Medizintechnik Promedt Gmbh | Method and device for treating aqueous liquids in human medical treatment |
EP1386625A1 (en) * | 2002-07-31 | 2004-02-04 | Air Liquide Santé (International) | Waste liquid treatment apparatus for hemodialyzers |
DE102017000533A1 (en) * | 2017-01-11 | 2018-07-12 | Fresenius Medical Care Deutschland Gmbh | Apparatus and method for the preparation of ready-to-use solutions for peritoneal dialysis |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230191010A1 (en) * | 2021-12-20 | 2023-06-22 | Fresenius Medical Care Holdings, Inc. | Hemodialysis system including ultraviolet chamber(s) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503333A (en) * | 1981-06-05 | 1985-03-05 | Baxter Travenol Laboratories | Antimicrobial ultraviolet irradiation of connector for continuous ambulatory peritoneal dialysis |
US4610782A (en) * | 1981-04-18 | 1986-09-09 | Bernd Tersteegen | Hemodialysis system having a thermoinsulated container |
US4620845A (en) * | 1981-06-05 | 1986-11-04 | Popovich Robert P | Method of peritoneal dialysis involving ultraviolet radiation of dialysis apparatus |
DD284603B5 (en) | 1989-06-07 | 1995-12-21 | Univ Berlin Humboldt | Apparatus for the treatment of blood or blood plasma with electromagnetic radiation |
EP0752391A2 (en) * | 1995-07-07 | 1997-01-08 | Nihon Trim Co. Limited | Water for medical treatment, production method thereof and dialysis apparatus using same |
US5653877A (en) * | 1992-12-09 | 1997-08-05 | Fm Mark Electronics Incorporated | Water purification system having multi-pass ultraviolet radiation and reverse osmosis chambers |
DE19640840A1 (en) | 1996-10-02 | 1998-04-16 | Fresenius Medical Care De Gmbh | Dialysis machine and method for disinfecting it |
-
1998
- 1998-06-04 DE DE29809867U patent/DE29809867U1/en not_active Expired - Lifetime
-
1999
- 1999-05-20 EP EP99955226A patent/EP1001819A1/en not_active Ceased
- 1999-05-20 WO PCT/EP1999/003446 patent/WO1999062573A1/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610782A (en) * | 1981-04-18 | 1986-09-09 | Bernd Tersteegen | Hemodialysis system having a thermoinsulated container |
US4503333A (en) * | 1981-06-05 | 1985-03-05 | Baxter Travenol Laboratories | Antimicrobial ultraviolet irradiation of connector for continuous ambulatory peritoneal dialysis |
US4620845A (en) * | 1981-06-05 | 1986-11-04 | Popovich Robert P | Method of peritoneal dialysis involving ultraviolet radiation of dialysis apparatus |
DD284603B5 (en) | 1989-06-07 | 1995-12-21 | Univ Berlin Humboldt | Apparatus for the treatment of blood or blood plasma with electromagnetic radiation |
US5653877A (en) * | 1992-12-09 | 1997-08-05 | Fm Mark Electronics Incorporated | Water purification system having multi-pass ultraviolet radiation and reverse osmosis chambers |
EP0752391A2 (en) * | 1995-07-07 | 1997-01-08 | Nihon Trim Co. Limited | Water for medical treatment, production method thereof and dialysis apparatus using same |
DE19640840A1 (en) | 1996-10-02 | 1998-04-16 | Fresenius Medical Care De Gmbh | Dialysis machine and method for disinfecting it |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003035145A1 (en) * | 2001-10-18 | 2003-05-01 | Medizintechnik Promedt Gmbh | Method and device for treating aqueous liquids in human medical treatment |
EP1386625A1 (en) * | 2002-07-31 | 2004-02-04 | Air Liquide Santé (International) | Waste liquid treatment apparatus for hemodialyzers |
DE102017000533A1 (en) * | 2017-01-11 | 2018-07-12 | Fresenius Medical Care Deutschland Gmbh | Apparatus and method for the preparation of ready-to-use solutions for peritoneal dialysis |
US11911547B2 (en) | 2017-01-11 | 2024-02-27 | Fresenius Medical Care Deutschland Gmbh | Apparatus and method for manufacturing ready-to-use solutions for peritoneal dialysis |
Also Published As
Publication number | Publication date |
---|---|
DE29809867U1 (en) | 1998-09-24 |
EP1001819A1 (en) | 2000-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69932984T2 (en) | System and treatment for the suppression of sepsis | |
US5032265A (en) | Method and system for producing sterile aqueous solutions | |
US6228255B1 (en) | Portable water treatment facility | |
DE102011008223B4 (en) | Dialysis treatment unit | |
DE3101159C2 (en) | Process for purifying blood and artificial kidney for carrying out the process | |
EP0692269B1 (en) | Haemo(dia)filtration device with filtrate flow control | |
DE3641843C2 (en) | ||
DE60126817T2 (en) | METHOD AND DEVICE FOR PRODUCING A STERILE INFUSION FLUID | |
EP2527303B1 (en) | Reverse osmosis assembly | |
DE69629467T2 (en) | TECHNIQUE FOR DISINFECTING EXTRACORPORAL LIQUID TREATMENT SYSTEMS | |
DE3634763C2 (en) | ||
US20110155657A1 (en) | Tee-connector for use in a filtration system | |
JPS60197289A (en) | Sterilized water and method and device for forming sterilized aqueous solution | |
CN110582308B (en) | System and method for producing microbial controlled fluids | |
EP1436025B1 (en) | Device for treating aqueous liquids | |
EP1001819A1 (en) | Ultraviolet transmitter for haemodialysis | |
DE3447989A1 (en) | Haemodialysis unit with a disinfecting apparatus | |
EP0960624A2 (en) | Haemodialysis machine | |
JP4188276B2 (en) | Cleaning and sterilizing method for hemodialysis system and cleaning and sterilizing apparatus for the system | |
RU2100295C1 (en) | Water treatment installation | |
DE60314073T2 (en) | Method and device for in-line preparation of fluid for a device for treating blood through an extracorporeal circuit | |
JPH078996A (en) | Method and system for producing aseptic aqueous solution | |
KR102576361B1 (en) | Water purifier apparatus for medical appliance | |
JPH07290065A (en) | Medical water and producing device therefor | |
JP6687509B2 (en) | Purified water supply system and its operating method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999955226 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09463291 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999955226 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1999955226 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999955226 Country of ref document: EP |